Oxford-Astrazeneca trial data show vaccine is at least 70 percent effective and easy to store as well
They looked at two different doses - half-dose followed by a full dose at least one month later was 90% effective while those give two full doses one month apart, was 62% effective.
Oxford-AstraZeneca COVID-19 vaccine will be available at cost price across world, says pharma head Olivier Nataf
Unlike the two vaccines produced by Moderna and Pfizer-BioNTech, which require ultra-cold storage, the AstraZeneca vaccine can be kept in the conventional fridge used to store vaccines around the world
Pfizer, BioNTech seek emergency use of COVID-19 shots in US, but vaccine still months away, say experts
Friday’s filing sets off a chain of events as the US FDA and its independent advisers debate if the shots are ready. If so, still the CDC will have to decide how the initial limited supplies are rationed out to anxiously awaiting Americans
COVID-19 vaccine to reach 30 cr by July-Aug, says Harsh Vardhan; healthcare workers, people above 65 yrs priority
Stating that everything is being decided by experts with a scientific point of view, the Union health minister expressed confidence that the COVID-19 vaccine will be ready in the next three to four months
Oxford vaccine candidate found safe in elderly, offered immunity against SARS-CoV-2 in all age groups
Two weeks after volunteers were administered a second dose, over 99 percent of them had neutralising antibody responses regardless of age.
Phase 3 of the COVISHIELD human trials will involve 1600 participants.
Oxford COVID-19 vaccine performing as 'expected', successfully induces immune response, says independent study
The vaccine, ChAdOx1 nCoV-19 and also known as AZD1222, is considered among the most advanced in the worldwide hunt for a viable vaccine against the novel coronavirus
Coronavirus Updates: 144 Maharashtra Police personnel test COVID-19 positive over past 24 hrs, cases rise to 24,023 in force
Coronavirus LIVE Updates: The Maharashtra Police said that 144 police personnel tested positive for COVID-19 in the last 24 hours, taking total cases to 24,023 in the force including 21,030 recoveries, 2,743 active cases and 250 deaths
WHO says delay in AstraZeneca COVID-19 vaccine trial is a 'wake-up call'; but won't delay the vaccine
An independent committee has been created to review the study’s safety data will let them know when it is safe to continue with the trials.
The US has invested billions of dollars in the fast development of vaccines against COVID-19 under Operation Warp Speed.
AstraZeneca's COVID-19 vaccine trial paused after 'potentially unexplained' adverse reaction in participant
In a statement issued on Tuesday evening, AstraZeneca said its "standard review process triggered a pause to vaccination to allow review of safety data"
Coronavirus Updates: With increased testing and relaxed lockdown more containment zones likely in Delhi
Coronavirus LATEST Updates: The number of COVID-19 containment zones in Delhi, which currently stand at 716, may be increased owing to further relaxations under 'Unlock' and doubling of coronavirus tests, officials said on Thursday
Pune's Bharti Vidyapeeth Medical College to begin phase 2 trials of Oxford COVID-19 vaccine from tomorrow
The institution, which is one of the 17 sites chosen by Serum Institute of India to conduct the trials, has been given a target of enlisting 300 to 350 volunteers
If successful, vaccines made in Australian would be shared with the country's neighbors, an official said.
According to the Indian Council of Medical Research, three Indian COVID-19 vaccines are in different phases of clinical testing at present
Health organizations including the CDC recommend routine immunization for HIV-positive people, who have been unilaterally left out of vaccine trials so far.
The drug firm is expected to deliver about 60 million doses of multiple vaccines against the coronavirus, including the one co-invented by Oxford and AstraZeneca, in the next few months
Serum Insititute has applied for regulatory approvals to start human trials of the vaccine in India starting August 2020.
Oxford's vaccine offers ‘good duration of immunity’ to COVID-19 compared to no vaccine: lead researcher
The vaccine has been licensed to AstraZeneca and is in its Phase III of its human trials in the UK.
In the race for a successful Coronavirus vaccine, a clinical trial conducted by Oxford has leapt ahead
Scientists said the first few million doses of their vaccine could be available by September, if it proves to be effective.